<unk>  (ETMA/P4), sold under the brand name Estrotate with Progesterone, is a combination medication of estradiol<unk>  (estradiol trimethylacetate; ETMA), an estrogen, and progesterone (P4), a progestogen, which was used in menopausal hormone therapy and the treatment of gynecological disorders but is no longer available. It contained 1 mg/mL ETMA and 10 mg/mL P4 in oil solution provided in vials and was administered by intramuscular injection at regular intervals. ETMA/P4 was introduced for medical use by 1949. It was one of the first combined estrogen and progestogen medications to be marketed, and was followed by the more well-known estradiol benzoate/progesterone (brand name Duogynon) in 1950. Other similar estrogen–progestogen preparations were also subsequently introduced.
Estradiol pivalate/progesterone
Estradiol enantate/algestone acetophenide
Estradiol benzoate/progesterone
Estradiol/dydrogesterone
Estradiol benzoate butyrate/algestone acetophenide
Mestranol/hydroxyprogesterone acetate
Estradiol hemisuccinate/progesterone
Estradiol/drospirenone